CORC  > 中国医学科学院 北京协和医学院
Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice
Jin, Wenyu; Huang, Wei; Chen, Liqing; Jin, Mingji; Wang, Qiming; Gao, Zhonggao; Jin, Zhehu
2018
卷号19期号:12
关键词momelotinib atopic dermatitis cytokine DNCB dendritic cell JAK STAT pathway
ISSN号1422-0067
DOI10.3390/ijms19123973
URL标识查看原文
收录类别SCIE ; PUBMED
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/6350590
专题中国医学科学院 北京协和医学院
推荐引用方式
GB/T 7714
Jin, Wenyu,Huang, Wei,Chen, Liqing,et al. Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice[J],2018,19(12).
APA Jin, Wenyu.,Huang, Wei.,Chen, Liqing.,Jin, Mingji.,Wang, Qiming.,...&Jin, Zhehu.(2018).Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice.,19(12).
MLA Jin, Wenyu,et al."Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice".19.12(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace